Legal Representation
Attorney
Lawrence M. Green
USPTO Deadlines
Next Deadline
90 days remaining
NOA E-Mailed - SOU Required
Due Date
April 11, 2026
Application History
34 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 24, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 24, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Aug 22, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Aug 22, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 24, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 23, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Mar 23, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Mar 23, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 28, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 28, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 28, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 28, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 6, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 5, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 5, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 5, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 28, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 26, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 26, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 26, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 11, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 14, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 14, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 25, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 12, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 6, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 6, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 6, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 1, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 1, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 1, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 1, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 8, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 26, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for treating Alzheimer's Disease, Parkinson's Disease, amyotrophic lateral sclerosis (ALS), Huntington's Disease, epilepsy, spinal cord injury, stroke, cerebral aneurysm, traumatic brain injury, concussion, a tumor, cancer, inflammation, viral and baterial infections, ataxia, brain atrophy, spinal cord atrophy, multiple sclerosis, traumatic spinal cord injury, ischemic or hemorrhagic myelopathy (myelopathy), global ischemia, hypoxic ischemic encephalopathy, embolism, fibrocartilage embolism myelopathy, thrombosis, nephropathy, chronic inflammatory disease, meningitis, and cerebral venous sinus thrombosis
Additional Information
Pseudo Mark
NEURO EXCEL
Classification
International Classes
005